|
WO2019130194A1
|
|
Novel drug products of picropodophyllin
|
|
WO2013132263A1
|
|
Picropodophyllin derivatives for use in therapy
|
|
WO2013132262A1
|
|
Picropodophyllin derivatives
|
|
WO2012047172A1
|
|
Picropodophyllin monohydrate or polymorph a in cancer therapy
|
|
AU2011312905A1
|
|
Picropodophyllin polymorphs B or C for use in cancer therapy
|
|
CN103189381A
|
|
New process for preparing cyclolignans
|
|
US2011178050A1
|
|
Use of cyclolignans for the treatment of a hyperactive immune system
|
|
AU2009201542A1
|
|
New use of specific cyclolignans
|
|
KR20090010161A
|
|
Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
|
|
AU2003288857A1
|
|
New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor
|
|
AU2003288858A1
|
|
Use of cyclolignans as inhibitors of igf-1 receptor for treatment of malignat diseases
|
|
EP1397368A1
|
|
New use of specific cyclolignans
|
